Mayinglong Pharmaceutical Group Co. Ltd Financials

Market Capitalization CN¥12.04 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	22.52
Forward PE	18.86
Price to Sales TTM	CN¥3.22
Price to Book MRQ	CN¥2.82
Enterprise to Revenue	2.57
Enterprise to EBITDA	15.41

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	14.27%
Operating Margin	23.91%
Return on Assets TTM	6.96%
Return on Equity TTM	13.13%

Income Statement

Revenue TTM	CN¥3,742,153,984
Revenue per Share TTM	CN¥8.70
Quarterly Revenue Growth	1.50%
Gross Profit TTM	CN¥1,743,536,256
EBITDA	CN¥694,057,303
Net Income to Common TTM	CN¥534,000,096
Diluted EPS TTM	CN¥1.24
Quarterly Earnings Growth YoY	3.00%

Balance Sheet

Total Cash MRQ	CN¥2,915,813,888
Total Cash per Share MRQ	CN¥6.76
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	4.79
Current Ratio MRQ	4.60
Book Value per Share MRQ	CN¥9.91

Cash Flow

Operating Cash Flow TTM	CN¥591,476,672
Levered Free Cash Flow TTM	CN¥211,756,816

600993 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	431,053,891
Float Shares	270,563,906
Avg 10 Volume	4,784,653
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	34.48%
% Held by Institutions	20.10%

Stock Price Summary

Beta	0.41
Fifty Two Week Low	CN¥21.33
Fifty Two Week High	CN¥31.46
Fifty Two Week Change	5.53%
Day 50 MA	CN¥27.90
Day 200 MA	CN¥25.88

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.60
Forward Annual Dividend Yield	5.78%
Trailing Annual Dividend Rate	CN¥0.40
Trailing Annual Dividend Yield	1.45%
Payout Ratio	32.26%
Dividend Date
Ex Dividend Date	2024-07-26
Last Split Factor
Last Split Date	2015-07-21